But other panelists said the drugs are an important option for patients who have bad reactions to newer drugs, including bisphosphonate drugs like Fosamax. "We have a whole lot of patients who can't take the other drugs, and I think our patients would be in worse shape without this," said Bart Clark, professor at the Mayo Clinic College of Medicine in Rochester, Minnesota.
CTV (AP)
Tags: calcitonin, CTV, Dr. Bart Clark, Fosamax, Mayo Clinic College of Medicine, Mayo Clinic Rochester, Pharmacology